Tilray Medical has expanded its European footprint across the Czech Republic through a new export and distribution partnership with Cansativa Group.
Denise Faltischek, Chief Strategy Officer and Head of International, Tilray Brands, Inc., said, "We are extremely proud to broaden our distribution across the Czech Republic and offer our EU-GMP certified medicinal cannabis products to help support medical cannabis patients in need. Our Tilray Medical team remains dedicated to patient advocacy across our international markets by providing quality medicinal cannabis for commercial, compassionate access, and research purposes."
For more information:
Tilray
www.tilray.com
